Santamarķa, Amparo <br/><br/>
Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population.  [electronic resource] 

 -  American journal of hematology  Aug 2004 
 - 348-52 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0361-8609 
<br/><br/><label>Standard No.: </label>10.1002/ajh.20108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Blood Coagulation Factors--analysis<br/>Blood Proteins--analysis<br/>Carboxypeptidase B2--blood<br/>Cardiovascular Diseases--blood<br/>Comorbidity<br/>Female<br/>Hemostasis<br/>Humans<br/>Hypercholesterolemia--blood<br/>Male<br/>Middle Aged<br/>Risk Factors<br/>Sex Factors<br/>Spain--epidemiology